Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Repare Therapeutics Inc. (RPTX)
|
Add to portfolio |
|
|
|
| Price: |
$20.95
| | Metrics |
| OS: |
42.1
|
M
| |
-38
|
% ROE
|
| Market cap: |
$882
|
M
| |
-68
|
% ROIC
|
|
Net cash:
|
$116
|
M
| |
$2.74
|
per share
|
|
EV:
|
$766
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($80.3)
|
M
| |
|
|
| EPS |
($2.23)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 0.0 | 0.0 | 0.0 | 12.8 | 6.2 |
| Revenue growth | | | -100.0% | 107.6% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 12.8 | 6.2 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | 0.0% | 0.0% |
| Selling, general and administrative | 116.3 | 54.4 | 26.4 | | |
| General and administrative | | | | 2.9 | 1.8 |
| EBIT | -108.5 | -55.2 | -27.7 | -12.8 | -6.2 |
| EBIT margin | | | | -100.0% | -100.0% |
| Pre-tax income | -108.6 | -54.7 | -27.0 | -14.2 | -7.8 |
| Income taxes | -1.7 | -1.3 | 0.2 | 0.0 | 0.0 |
| Tax rate | 1.5% | 2.4% | | 0.2% | 0.0% |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | | | | 0.0% | 0.0% |
| |
| Diluted EPS | $0.00 | $0.00 | $0.00 | | |
| Shares outstanding (diluted) | 37.8 | 20.0 | 1.5 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|